4 years ago
VIR
AnalystsJoseph StringerJoseph Stringer's Stock Forecasts
AnalystsJoseph Stringer
Analyst Ranking
Top 2%
#60 out of 5510 analysts
Average Return
+31.24%
Win Rate
47%159 out of 339
Risk vs Reward
Poor
Good
Joseph Stringer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,195.38% | $17.09 | $221.38 | 2025-04-10 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +835.67% | $23.66 | $221.38 | 2025-03-07 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +820.50% | $24.05 | $221.38 | 2025-06-04 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +811.78% | $24.28 | $221.38 | 2025-05-23 - 2026-01-06 | Buy |
Avidity Biosciences IncRNAM | +454.80% | $7.81 | $43.33 | 2023-11-29 - 2024-11-27 | Buy |
Joseph Stringer Analyst Color
Get additional color on Joseph Stringer's coverage of popular stocks
Joseph Stringer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ionis Pharmaceuticals IncIONS | 29 | Buy | $86.00 | +53.52% | Reiterates | 7 days ago |
Gilead Sciences IncGILD | 12 | Buy | $170.00 | +16.72% | Reiterates | a month ago |
Bioage Labs IncBIOA | 2 | Buy | $35.00 | +281.68% | Maintains | a month ago |
Phathom Pharmaceuticals IncPHAT | 52 | Buy | $22.00 | +153.75% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 26 | Buy | $357.00 | +38.37% | Maintains | a month ago |
Annexon IncANNX | 18 | Buy | $25.00 | +472.08% | Maintains | 2 months ago |
Shattuck Labs IncSTTK | 1 | Buy | $17.00 | +168.56% | Maintains | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 21 | Hold | N/A | N/A | Downgrades | 5 months ago |
Stoke Therapeutics IncSTOK | 23 | Buy | $40.00 | +33.69% | Maintains | 6 months ago |
Rhythm Pharmaceuticals IncRYTM | 31 | Buy | $130.00 | +28.64% | Maintains | 6 months ago |
Vir Biotechnology IncVIR | 20 | Buy | $18.00 | +66.51% | Maintains | 7 months ago |
Vaxcyte IncPCVX | 18 | Buy | $110.00 | +84.84% | Maintains | 8 months ago |
Cidara Therapeutics IncCDTX | 16 | Hold | N/A | N/A | Downgrades | 10 months ago |
Avidity Biosciences IncRNAM | 19 | Hold | $65.00 | +340.68% | Downgrades | 10 months ago |
Moderna IncMRNA | 9 | Hold | N/A | N/A | Reiterates | a year ago |
Inozyme Pharma IncINZY | 20 | Hold | $12.00 | N/A | Downgrades | a year ago |
Vertex Pharmaceuticals IncVRTX | 6 | Hold | N/A | N/A | Reiterates | a year ago |
Lexicon Pharmaceuticals IncLXRX | 13 | Hold | N/A | N/A | Reiterates | 2 years ago |
Pliant Therapeutics IncPLRX | 17 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Tvardi Therapeutics IncTVRD | 14 | Buy | $60.00 | N/A | Reiterates | 2 years ago |
Acadia Pharmaceuticals IncACAD | 4 | Buy | $37.00 | N/A | Upgrades | 3 years ago |
Intercept Pharmaceuticals IncICPT | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zealand Pharma AZEAL | 1 | Buy | $32.00 | N/A | Maintains | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Theravance Biopharma IncTBPH | 2 | Buy | $18.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.